Table 2.

Comparison of risks of long-term sequelae between the SNJ cases and reference cohort.

Different categories	Reference cohort (n = 12,579)	SNJ 2000–2003 follow-up cohort (n = 66,983)
	n (%)	n (%)	OR	aORa
Developmental delay	614 (4.9)	6,630 (9.9)	2.14*	1.63***
Infantile cerebral palsy	63 (0.5)	1,009 (1.5)	3.03*	1.35*
Lack of expected normal physiological development in childhood	218 (1.73)	2,277 (3.4)	1.99*	1.5***
Hearing loss	169 (1.3)	2,047 (3.1)	2.31*	1.74***
Developmental speech disorders	250 (2.0)	2,587 (3.9)	1.98*	1.51***
Dysarthria	178 (1.4)	1,553 (2.3)	1.65*	1.46***
Mental retardation	118 (0.9)	1,169 (1.8)	1.87*	1.27*
ADHD	324 (2.58)	2,523 (3.8)	1.48*	1.3***
Autism	61 (0.5)	593 (0.9)	1.83*	1.69***

SNJ significant neonatal jaundice, ADHD attention deficit hyperactivity disorder.

*P 0.05; **P 0.01; ***P 0.001.

^aAdjusted for gender, urbanization levels and comorbid perinatal conditions (prematurity, hemolytic disease of newborn, and congenital or chromosome anomalies).